Asia Pacific Opioids Drug Market Forecast 2019-2027
- Report Description Table of Contents
- FAQs
KEY FINDINGS
The regional market for opioid drugs in the Asia-Pacific is rapidly growing at 3.06% CAGR during the forecast period 2019-2027, where it was valued $XX million in its base year of 2018. The rising awareness about palliative care that is necessary for patients suffering from incurable diseases is expected to drive the market growth in this region. China, India, Japan, Australia, South Korea & Rest of Asia Pacific are deliberated for this study.
MARKET INSIGHTS
The sale of sustained-release formulations of opioid drugs and other forms of opioid-dependent pain relief medications are expected to pave more ways for the market growth. Also, the reduction in the use of non-addictive pain relievers is going to enhance the use of addiction-deterrent variants of opioid drugs in the upcoming years. Japan owns the largest shares of the Asia Pacific opioid drugs market, mainly because of the higher frequency of chronic and severe pain, although the market growth can get obstructed due to the strict and restrictive laws for its prescriptions and the stigma associated with opioid addiction.
COMPETITIVE INSIGHTS
Hikma Pharmaceuticals PLC, Acura Pharmaceuticals, Inc., Lannett Co. Inc., BioDelivery Sciences International, Inc., Sun Pharmaceutical Industries Limited (Sun Pharma), Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Allergan PLC, Egalet Corp., Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A. and Teva Pharmaceutical Industries Ltd. are the predominant revenue reapers for the Asia-Pacific opioid drugs market.
The regional market for opioid drugs in the Asia-Pacific is rapidly growing at 3.06% CAGR during the forecast period 2019-2027, where it was valued $XX million in its base year of 2018. The rising awareness about palliative care that is necessary for patients suffering from incurable diseases is expected to drive the market growth in this region. China, India, Japan, Australia, South Korea & Rest of Asia Pacific are deliberated for this study.
MARKET INSIGHTS
The sale of sustained-release formulations of opioid drugs and other forms of opioid-dependent pain relief medications are expected to pave more ways for the market growth. Also, the reduction in the use of non-addictive pain relievers is going to enhance the use of addiction-deterrent variants of opioid drugs in the upcoming years. Japan owns the largest shares of the Asia Pacific opioid drugs market, mainly because of the higher frequency of chronic and severe pain, although the market growth can get obstructed due to the strict and restrictive laws for its prescriptions and the stigma associated with opioid addiction.
COMPETITIVE INSIGHTS
Hikma Pharmaceuticals PLC, Acura Pharmaceuticals, Inc., Lannett Co. Inc., BioDelivery Sciences International, Inc., Sun Pharmaceutical Industries Limited (Sun Pharma), Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Allergan PLC, Egalet Corp., Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A. and Teva Pharmaceutical Industries Ltd. are the predominant revenue reapers for the Asia-Pacific opioid drugs market.
Asia Pacific Opioids Drug Market Forecast 2019-2027
Published By :Inkwood Research
How to Purchase
Purchase reports from our site in few easy clicks. Please follow the description given below to complete your purchase process.
Step 1:
Select the report title of your interest, and Click on Buy Now button next to the Price option.
Step 2:
You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.
Step 3:
After SignUp/Login, you will arrive at our Payment Page on Paypal. You will see your Order Summary as well as an option to Choose a way to pay. Select a Payment option from Pay with a Paypal account OR Pay with a Debit or Credit Card. MarketReportOnline accepts Visa, MasterCard, American Express and Discover through Paypal. Fill up the required details in the option of your choice.
Step 4:
Once you follow the required process in Step 3 as mentioned above, you have successfully completed the purchase process.
Step 5:
Once you have successfully completed the purchase process, you will receive a confirmation email. The report will then be emailed to you directly by the publisher, as per our agreement with the publisher. For Orders that are placed after working hours, the delivery of the reports will be made on the next business day. For orders that are placed during weekends, the delivery of the reports will be made on the next 'working' business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us.